EDGAR Filing Documents for 0001387131-13-002429

Form 8-K - Current report:

SEC Accession No. 0001387131-13-002429

Filing Date

2013-07-02

Accepted

2013-07-01 17:59:11

Documents

Period of Report

2013-07-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURERNT REPORT	admp-8k_062613.htm	8-K	61524
2	SUBSCRIPTION AGREEMENT	ex10-1.htm	EX-10.1	409368
3	SECURED CONVERTIBLE PROMISSORY NOTE	ex10-2.htm	EX-10.2	95198
4	ESCROW AGREEMENT	ex10-3.htm	EX-10.3	114648
5	SECURITY AGREEMENT	ex10-4.htm	EX-10.4	308682
6	INTERCREDITOR AGREEMENT	ex10-5.htm	EX-10.5	111829
7	PRESS RELEASE	ex99-1.htm	EX-99.1	9218
	Complete submission text file	0001387131-13-002429.txt		1111904

Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130

Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400

Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)